Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines in the United Kingdom. Its lead drug candidate consists of OCT461201, a cannabinoid like new chemical entity, which is in phase I clinical trial for potential therapy to peripheral neuropathies and irritable bowel syndrome.… Read more
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) - Total Assets
Latest total assets as of October 2023: $2.79 Million USD
Based on the latest financial reports, Oxford Cannabinoid Technologies Holdings Plc (OCTHF) holds total assets worth $2.79 Million USD as of October 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oxford Cannabinoid Technologies Holdings Plc - Total Assets Trend (2018–2023)
This chart illustrates how Oxford Cannabinoid Technologies Holdings Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oxford Cannabinoid Technologies Holdings Plc - Asset Composition Analysis
Current Asset Composition (April 2023)
Oxford Cannabinoid Technologies Holdings Plc's total assets of $2.79 Million consist of 99.8% current assets and 0.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 51.1% |
| Accounts Receivable | $2.19 Million | 48.7% |
| Inventory | $-2.19K | -0.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.27K | 0.2% |
| Goodwill | $-1.86K | 0.0% |
Asset Composition Trend (2018–2023)
This chart illustrates how Oxford Cannabinoid Technologies Holdings Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oxford Cannabinoid Technologies Holdings Plc's current assets represent 99.8% of total assets in 2023, a decrease from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 51.1% of total assets in 2023, up from 5.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 48.7% of total assets.
Oxford Cannabinoid Technologies Holdings Plc Competitors by Total Assets
Key competitors of Oxford Cannabinoid Technologies Holdings Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Oxford Cannabinoid Technologies Holdings Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oxford Cannabinoid Technologies Holdings Plc generates 0.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oxford Cannabinoid Technologies Holdings Plc is currently not profitable relative to its asset base.
Oxford Cannabinoid Technologies Holdings Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.32 | 5.79 | 1.41 |
| Quick Ratio | 3.32 | 5.79 | 1.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.95 Million | $ 6.12 Million | $ 295.97K |
Oxford Cannabinoid Technologies Holdings Plc - Advanced Valuation Insights
This section examines the relationship between Oxford Cannabinoid Technologies Holdings Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.22 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | -62.0% |
| Total Assets | $4.50 Million |
| Market Capitalization | $2.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oxford Cannabinoid Technologies Holdings Plc's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Oxford Cannabinoid Technologies Holdings Plc's assets decreased by 62.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Oxford Cannabinoid Technologies Holdings Plc (2018–2023)
The table below shows the annual total assets of Oxford Cannabinoid Technologies Holdings Plc from 2018 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-04-30 | $4.50 Million | -61.96% |
| 2022-04-30 | $11.82 Million | -22.31% |
| 2021-04-30 | $15.21 Million | +1057.72% |
| 2020-04-30 | $1.31 Million | -43.69% |
| 2019-04-30 | $2.33 Million | +833.30% |
| 2018-04-30 | $250.01K | -- |